Hye Sook Kim

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Internal Carotid Artery

Small Cell Lung Cancer

Top Venues

JCO precision oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hye Sook Kim, Jong-Kwang Kim, Jeong Hyeon Lee, Young Joo Lee, Geon Kook Lee, Ji-Youn Han
Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression. JCO precision oncology 8 (2024)
Hye Sook Kim, Jong-Kwang Kim, Jeong Hyeon Lee, Young Joo Lee, Geon Kook Lee, Ji-Youn Han
Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression. JCO precision oncology 8 (2024)
Hye Sook Kim, Jong-Kwang Kim, Jeong Hyeon Lee, Young Joo Lee, Geon Kook Lee, Ji-Youn Han
Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression. JCO precision oncology 8 (2024)
Hye Sook Kim, Kun Young Lim, Soo-Hyun Lee, Hyae Young Kim, Youngjoo Lee, Ji-Youn Han
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancer. Cancer medicine (2023)
Hye Sook Kim, Kun Young Lim, Soo-Hyun Lee, Hyae Young Kim, Youngjoo Lee, Ji-Youn Han
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancer. Cancer medicine (2023)
Hye Sook Kim, Kun Young Lim, Soo-Hyun Lee, Hyae Young Kim, Youngjoo Lee, Ji-Youn Han
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancer. Cancer medicine (2023)